Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas

OBJECTIVE: To evaluate the efficacy, safety, and prognostic value of low-dose apatinib in combination with temozolomide in the treatment of primary or recurrent high-grade gliomas (HGGs). METHODS: A retrospective analysis of patients with postoperative and recurrent HGGs treated in our hospital from...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ming, Gao, Liying, Liu, Xiaofeng, Dong, Fang, Su, Qun, Zhang, Yanping, Li, Fengju, Wang, Hulan, Han, Pengbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467810/
https://www.ncbi.nlm.nih.gov/pubmed/36106030
http://dx.doi.org/10.1155/2022/3181133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467810/
https://www.ncbi.nlm.nih.gov/pubmed/36106030
http://dx.doi.org/10.1155/2022/3181133

Ejemplares similares